Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$29.85 +0.33 (+1.12%)
As of: Sep 30, 2026 · 2:36 PM EDT

Lakefront Biotherapeutics (LKFT) Net Margin (2014 - 2026)

Updated

Lakefront Biotherapeutics (LKFT) reported Net Margin of 17.39% for the quarter ended Jun 30, 2026, up 179.20 percentage points from -161.81% a year earlier but down 206.21 percentage points from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) Net Margin (2014 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Lakefront Biotherapeutics' Net Margin came in at 32411.68%, up 11211.65 percentage points year-over-year; for the year ended Dec 31, 2025, it was 28.85%, up 1.97 percentage points from the prior year.

  • Net Margin has a five-year change of +92.74 percentage points (years ended Dec 2020 to Dec 2025).
  • By year, Net Margin came in at 26.88% in the year ended Dec 31, 2024 (-61.43 pp), 88.31% in the year ended Dec 31, 2023 (+178.67 pp), -90.36% in the year ended Dec 31, 2022 (-46.32 pp) and -44.04% in the year ended Dec 31, 2021 (+19.85 pp).
  • Five-year quarterly Net Margin spans a low of -284.23% in the quarter ended Sep 30, 2025 and a high of 197421.93% in the quarter ended Dec 31, 2024.
  • Year over year, Net Margin gained in three of the last seven quarters, with an average year-over-year change of -473.56 percentage points.
  • The high point for year-over-year Net Margin in five years was the quarter ended Dec 31, 2024 (a gain of 158502.69 percentage points); the low point was the quarter ended Dec 31, 2025 (a drop of 161749.49 percentage points).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at 223.61% (quarter ended Mar 31, 2026), 35672.45% (quarter ended Dec 31, 2025) and -284.23% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 21.86%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 21.27%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -8.04%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 22.61%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 18.81%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 23.62%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -134.51%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 32.99%
10 Lakefront Biotherapeutics 1.95 Bn 1.95 Bn 3.51 Mn 17.39%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.39%
Mar 31, 2026 223.61%
Dec 31, 2025 35,672.45%
Sep 30, 2025 -284.23%
Jun 30, 2025 -161.81%
Mar 31, 2025 -204.60%
Dec 31, 2024 197,421.93%
Sep 30, 2024 -13.67%
Mar 31, 2024 144.51%
Dec 31, 2023 38,919.25%
Sep 30, 2023 42.17%
Jun 30, 2023 8.50%
Mar 31, 2023 39.62%
Sep 30, 2022 15.80%
Jun 30, 2022 -13.82%
Mar 31, 2022 -9.76%
Sep 30, 2021 -37.62%
Jun 30, 2021 -46.02%
Mar 31, 2021 8.25%
Dec 31, 2020 56.92%
API Access

Lakefront Biotherapeutics Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=LKFT&period=max&api_key=YOUR_API_KEY